News and lnsights

04-15 2019
Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard University
Harvard College China Forum, an annual Harvard tradition for 22 years, welcomed and opened to 1,200 domestic and international participants and over 100 domestic and international speakers in Cambridge, Massachusetts, USA, on April 12-14, 2019.
Learn More
04-07 2019
Biocytogen’s Integrated One-stop Preclinical Services and the RenMab Mouse Shine at AACR 2019
American Association for Cancer Research (AACR) Annual Meeting 2019 was held in Atlanta, Georgia from March 29 to April 3, 2019。
Learn More
01-29 2019
Former Swedish Prime Minister Visits Biocytogen
Former Swedish Prime Minister, former president of the European Council Mr. Fredrik Reinfeldt and Executive Chairman of Nordic Growth Technology (NGT) Partners, professor Niclas Adler visited Biocytogen on January 23, 2019.
Learn More
05-02 2018
Biocytogen showcases innovative gene-editing strategies at Experimental Biolo
BiocytogenTM Gene Targeting Services participated at the Experimental Biology (EB) 2018 meeting in San Diego, CA, April 22-24. This conference was comprised of more than 14,000 attendees from academic, industry and government sectors, and covered topics and advances in anatomy,
Learn More
09-04 2018
Immuno-Oncology (IO) Summit 2018
Biocytogen was excited meeting booth attendees at the Immuno-Oncology (IO) Summit 2018
Learn More
10-17 2018
The Groundbreaking Ceremony for Model Organism Research Base of Biocytogen China was held on Sep. 8, 2018 at Haimen Biotech and Pharmaceutical Park.
Occupying a land area of approximately 6.53 hectares and a built-up area of 115,000 square meters, the project costs CNY 1.016 billion and is expected to be completed by the end of 2019.
Learn More
© 2018 Beijing Biocytogen Co., Ltd. All rights reserved. Technical support: fast help cloud